Overall Score

Growth

Revenue base remains modest at a 0.53x price-to-sales ratio, suggesting limited growth expectations are embedded.

Asset turnover of 0.93x indicates acceptable but not exceptional efficiency in converting assets into sales.

Profitability

Margins remain negative, with EBIT margin at -10.5% and net profit margin at -13.9%.

Returns are still deeply negative, including ROE at -35.5% and ROIC at -11.6%.

Financial Health

Liquidity is solid with a current ratio of 2.28x and quick ratio of 1.23x.

Leverage appears manageable, with debt-to-equity at 1.22x and net debt-to-EBITDA negative, indicating net cash relative to EBITDA.

Cash Flow

Free cash flow remains positive, with a 9.1% FCF yield and FCF of $22.3M TTM.

Cash conversion is decent, as operating cash flow covers capex by 2.53x.

Valuation

Valuation is inexpensive on sales and cash flow, with EV/sales at 0.97x and price-to-free-cash-flow at 11.0x.

Earnings-based multiples are distorted by losses, so the negative P/E is not meaningful.